Diabetes Clinical Trials in Atlanta

Showing 401-420 of 621 trials

Adult Accuracy Study of the Enlite 3 Glucose Sensor

NCT02246582

The purpose of this study is to demonstrate the performance of the Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen and used with the Guardian Mobile App and 640G Pump in subjects aged 14-75 years with type 1 or type 2 diabetes.

Type 1 DiabetesType 2 Diabetes

Medtronic MiniMed, Inc.118 participantsStarted Sep 2014

Escondido, California, United States • Walnut Creek, California, United States • Aurora, Colorado, United States +3 more locations

COMPLETEDPhase 4< 1 mile

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

NCT02025907

The purpose of this study is to assess the effect of canagliflozin (JNJ-28431754) compared to placebo in the treatment of participants with Type 2 Diabetes Mellitus (T2DM), who have inadequate glycemic control on maximally or near-maximally effective doses of metformin and sitagliptin.

Diabetes Mellitus, Type 2

Janssen Research & Development, LLC218 participantsStarted Feb 2014

Montgomery, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +54 more locations

Adult Accuracy Study of the Enlite 3 Glucose Sensor

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

Diabetes Trials in Other Cities

T and B Cell Responses in Autoimmune Diseases

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

Connecting Smartphones With Electronic Health Record to Facilitate Behavioral Goal Monitoring in Diabetes Care

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.

Other Conditions in Atlanta